Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
VA
Vivani Medical, Inc. Common Stock (DE)
VANI
Mkt Cap
$101.9M
Volume
360.40K
Next Earnings
November 12th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
VA
VANI
VA
Vivani Medical, Inc. Common Stock (DE)
VANI
News
·
Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?
Mkt Cap
$103.7M
Volume
360.40K
Next Earnings
November 12th
Chart
Financials
Earnings
News
About
Insider
Filings
Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?
Novo Nordisk, which pioneered GLP-1 weight-loss drugs but lost market leadership to Eli Lilly, is attempting a comeback through product innovation. The company has launched a pill version of Wegovy and partnered with Vivani Medical to develop an implant that could deliver the drug once or twice yearly, potentially revolutionizing convenience in the GLP-1 market. While Eli Lilly maintains a stronger market position and higher valuation, Novo Nordisk's continued innovation could help it regain competitive ground.
The Motley Fool · Aug 29, 2026
Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream
EmergingGrowth.com announces the 94th Emerging Growth Conference scheduled for July 15-16, 2026, featuring presentations from 20+ small-cap and emerging growth companies across sectors including mining, technology, healthcare, and renewable energy. The virtual conference allows companies to present their strategies, products, and announcements to the investment community.
GlobeNewswire Inc. · Jul 14, 2026
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
Vivani Medical announced a definitive merger agreement to merge its wholly owned subsidiary Cortigent, Inc. with ClearOne, Inc. Under the transaction, Cortigent will become a wholly owned subsidiary of ClearOne, which will be renamed Cortigent Holdings, Inc. and trade under ticker symbol 'CRGT'. ClearOne will raise $10-15 million in concurrent financing. Vivani will receive 12.5 million shares and own 59.4-67.5% of the combined company. The transaction is expected to close in Q3 2026.
GlobeNewswire Inc. · Jul 2, 2026
Vivani Medical, Inc. Announces Pricing of Common Stock Offering
Vivani Medical announced a registered direct offering of 1.69 million shares and concurrent private placement of 1.35 million shares at $1.48 per share, raising approximately $4.5 million gross proceeds. The funds will support ongoing research and clinical development of the company's drug implant candidates. Chairman Gregg Williams participated in the private placement.
GlobeNewswire Inc. · Jan 26, 2026
Vivani Medical, Inc. Announces Pricing of Common Stock Offering
Vivani Medical is raising approximately $15.7 million through a registered direct offering of 6 million shares and a private placement of 3.7 million shares at $1.62 per share. The proceeds will fund research, clinical development, and general corporate purposes.
GlobeNewswire Inc. · Oct 26, 2025
Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now
EmergingGrowth.com announces the schedule for the 78th Emerging Growth Conference, featuring presentations from various companies across different growth sectors.
GlobeNewswire Inc. · Jan 15, 2025
EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year - Benzinga
Vivani Medical plans to initiate the first clinical study for its NPM-115 program, a 6-month GLP-1 implant for chronic weight management, in Australia in Q4 2024. The study will evaluate the safety, tolerability, and pharmacokinetic profile of the exenatide implant compared to weekly semaglutide injections and Bydureon BCise.
Benzinga · Jul 11, 2024
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin. Bitdeer Technologies Group shares jumped 10.2% to $7.45 on Monday. Here are some other stocks moving in today's mid-day session. Gainers BitFuFu Inc. (NASDAQ: FUFU) shares jumped 107% to $13.20 amid volatility following the company's recent business combination with Arisz Acquisition Corp and listing on the Nasdaq. Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) climbed 89% to $5.31 after the company announced FDA clearance to recruit teen subjects into both of its ongoing Netherton Syndrome clinical studies. Renalytix Plc (NASDAQ: RNLX) gained 52.8% to $1.5890 after the company announced that it received an unsolicited approach from a publicly listed strategic diagnostics company. Phunware, Inc. (NASDAQ: PHUN) climbed 42.7% to $10.11. Phunware is expected to report fourth-quarter results on March 12, 2024. Ainos, Inc. (NASDAQ: AIMD) gained 39.4% to $1.4650. Jaguar Health, Inc. (NASDAQ: JAGX) shares climbed 38.2% to $0.1223 after surging 50% on Friday. Cardiff Oncology, Inc. (NASDAQ: CRDF) rose 31.6% to $3.83 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial. The E.W. Scripps Company (NASDAQ: SSP) gained 31.3% to $4.94. E.W. Scripps Director Charles L. Barmonde acquired a total of 10,500 shares an average price of $4.28. Helius Medical Technologies, Inc. (NASDAQ: HSDT) climbed 30% to $5.91. Helius Medical Technologies announced it secured HCPCS codes for portable neuromodulation stimulator mouthpiece and controller. Kineta, Inc. (NASDAQ: KA) gained 27% to $1.14. Kineta recently announced a restructuring and the exploration of strategic alternatives. BigBear.ai Holdings, Inc. (NYSE: BBAI) rose 25% to $4.3472. Critical Metals Corp. (NASDAQ: CRML) gained 24.4% to $12.44. Ocean Biomedical, Inc. (NASDAQ: OCEA) gained 22% to $2.44. Reliance Global Group, Inc. (NASDAQ: RELI) rose 21.7% to $0.6299 after gaining 11% on Friday. Akero Therapeutics, Inc. (NASDAQ: AKRO) ...
Benzinga · Mar 4, 2024
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. Zscaler posted better-than-expected earnings and sales results for its second quarter on Thursday. The company said it expects fiscal year 2024 non-GAAP income from operations between $395 million and $400 million and net income per share between $2.73 and $2.77. Zscaler shares fell 10.1% to $217.43 on Friday. Here are some other stocks moving in today's mid-day session. Gainers BioVie Inc. (NASDAQ: BIVI) shares climbed 96.1% to $2.4319. BioVie's Ne3107 demonstrated potential improvements in motor and non-motor symptoms for Parkinson's disease patients and may be realigning physiological processes for Alzheimer's patients. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) gained 68.4% to $3.4350. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder. Cardiff Oncology, Inc. (NASDAQ: CRDF) shares rose 41.5% to $2.50 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial. Minim, Inc. (NASDAQ: MINM) shares rose 41.4% to $6.09. On Feb. 20, Minim entered into an employment agreement with David Lazar to engage him as CEO, CFO, following resignation of Jeremy Hitchcock. The RealReal, Inc. (NASDAQ: REAL) gained 39.1% to $2.4613 following upbeat quarterly results. Nxu, Inc. (NASDAQ: NXU) shares gained 36.4% to $1.09 after the company announced it successfully charged a Tesla Cybertruck on Feb. 26. Jaguar Health, Inc. (NASDAQ: JAGX) climbed 35.3% to $0.0798. Dell Technologies Inc. (NYSE: DELL) rose 26.3% to $119.52 as the company reported better-than-expected fourth-quarter financial results and increased its annual cash dividend by 20%. Sweetgreen, Inc. (NYSE: SG) gained 26% to $16.05 after the company reported better-than-expected fourth-quarter financial results. MMTec, Inc. (NASDAQ: MTC) climbed 25% to $1.61. Everbridge, Inc. (NASDAQ: EVBG) rose 24.5% to $35.19 after it amended and restated the previously announced merger agreement with Thoma Bravo. NetApp, Inc. (NASDAQ: NTAP) shares gained 24.4% to $110.85 after the company reported better-than-expected third-quarter financial results ...
Benzinga · Mar 1, 2024
Tips for Understanding Penny Stocks Fundamentals
Use these tips to understand fundamentals with penny stocks The post Tips for Understanding Penny Stocks Fundamentals appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks · Feb 29, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
VA
VANI
Vivani Medical, Inc. Common Stock (DE)
Buy
Sell
Market
Limit
Soon
VANI
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any VANI yet.
Related Tickers
CO
COCH
—
Earnings